Singh Biotechnology, LLC
Singh Biotechnology, based in Brooksville, FL, specializes in the discovery and development of unique proprietary therapeutics aimed at treating cancers, autoimmune disorders, and ophthalmologic diseases. The company leverages its innovative Single Domain Antibody (sdAb) technology platform to engineer miniature antibodies that specifically target intracellular proteins, offering advantages akin to both biologics and small molecules.
With a focus on addressing critical health challenges, Singh Biotechnology's dedication to research has led to the FDA granting orphan drug designation for its anti-STAT3 B VHH13 sdAb SBT-100 for the treatment of pancreatic cancer in 2016 and for osteosarcoma in 2017. This novel approach facilitates the creation of bi-specific antibodies capable of crossing the blood-brain barrier, thereby enhancing therapeutic options for a variety of diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.